GRI: GRI Bio, Inc. Company Buyout Price
The asset value for GRI Bio, Inc. (GRI) tracked on the GURU.Markets chart is -7.63, illustrating the price action of the company developing immune drugs. The business implements ESG environmental standards and strictly adheres to bioethics. High bioengineering costs and regulatory oversight limit the entry of new players into the NKT therapy niche. Research stability is ensured through the distribution of orders across various scientific centers and the control of reagent supplies.
Analytical breakdowns for GRI Bio, Inc.
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:GRI (GRI Bio Inc)
To objectively assess the operational efficiency of GRI Bio, Inc., investors must consider the total value of all business rights, including net debt. The EV history reflects market capitalization adjusted for cash and liabilities, allowing for an assessment of the actual buyout price of the company, taking into account its intellectual property and outsourcing model for bio-substance production.
Who GRI Bio, Inc. competes with
Value Adjusted for Debt and Cash argenx N.V. ARGX|Enterprise Value BNTX (BioNTech Group)|ABVX: Company Buyout Price|Total Company Value ADMA Biologics (ADMA)|protagonist-inc.com (PTGX) - Full Business Value|IMVT - Enterprise Value|Value Adjusted for Debt and Cash Kiniksa Pharmaceuticals, Ltd.|Enterprise Value GRFS|Enterprise Value ADPT (Adaptive Biotechnologies Inc.)|Total Company Value Celldex Therapeutics|auriniapharma.com - Value Adjusted for Debt and Cash|BCRX: Total Company Value|VERA - Real Price to Acquire Entire Company|DNTH: Enterprise Value|Enterprise Value Pharvaris Pharma|ABCL - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash tourmalinebio.com|PGEN (Precigen) - Enterprise Value|Company Buyout Price PHAR (Pharming Group NV)|Nektar - Total Company Value|Upstream Pharma - Real Price to Acquire Entire Company|ZBIO: Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharma) - Enterprise Value|Total Company Value Septerna Corp (SEPN)|Business Value Pieris Corp|Savara Inc. - Enterprise Value|Total Enterprise Value rigel.com (RIGL)|ANAB (AnaptysBio) - Enterprise Value|Astria Therapeutics Inc - Full Takeover Company Value|Total Company Value enGene Bio (ENGN)|RAPT - Value Adjusted for Debt and Cash|aerovatetx.com - Enterprise Value|Company Buyout Price aclaristx.com|KYTX - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Tiziana Life Sciences Ltd.|Enterprise Value Cabaletta Bio, Inc (CABA)|Total Company Value Ventyx Biosciences, Inc (VTYX)|Enterprise Value THTX|avalotx.com - Company Buyout Price|ELDN (Eledon Pharmaceuticals, Inc.) - Total Company Value|Agenus, Inc. (AGEN) - Total Enterprise Value|Real Price to Acquire Entire Company Climb Bio, Inc. CLYM|Zura Bio Ltd (ZURA) - Value Adjusted for Debt and Cash|ATYR: Enterprise Value|Company Buyout Price ADAG|Total Company Value ImageneBio Inc IMA|Business Value shattucklabs.com (STTK)|Equillium - Enterprise Value|CNTB - Real Price to Acquire Entire Company|Real Price to Acquire Entire Company IMUX (Immunic Inc)|ATRA - Company Buyout Price|Enterprise Value IFRX (inflarx.de)|XFOR (X4 Pharmaceuticals Inc.) - Full Takeover Company Value|ACET - Total Company Value|Value Adjusted for Debt and Cash Celularity Corp|INMB (INmune Bio, Inc.) - Enterprise Value|Company Buyout Price BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. (KZR) - Total Company Value|Full Business Value SAB Biotherapeutics Inc. SABS|Enterprise Value Akari Therapeutics plc (AKTX)|ENLV - Value Adjusted for Debt and Cash|QTTB: Enterprise Value|GOVX (geovax.com) - Enterprise Value|EDSA - Total Company Value|Value Adjusted for Debt and Cash IBIO|Total Company Value CARM (Carisma Therapeutics)|Real Price to Acquire Entire Company XTL Bio (XTLB)|Enterprise Value BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Enterprise Value|Real Price to Acquire Entire Company Aptevo (APVO)|AIM - Value Adjusted for Debt and Cash|aditxt.com - Enterprise Value|XRTX (XORTX Corp) - Company Buyout Price|Total Company Value HIND|Real Price to Acquire Entire Company REVB|Total Company Value INDP (Indaptus Therapeutics, Inc.)|Real Price to Acquire Entire Company Scinai Immunotherapeutics Ltd SCNI|Real Price to Acquire Entire Company CALI (CalciMedica)|Affimed NV - Enterprise Value|Allakos Therapeutics (ALLK) - Total Company Value|HOOK - Business Value|Enterprise Value IGMS|iTeos Therapeutics Inc (ITOS) - Total Enterprise Value|Ocean Bio - Enterprise Value|Full Takeover Company Value TCBP|Third Harmonic Bio (THRD) - Total Company Value